Latest News & Updates

• 

  The Proliferation of Ketamine Infusion Clinics Presents Opportunities and Uncertainty

  

  By David Khalaf

  on October 30, 2019

  In a cautious win for off-label prescribing, one of the world’s most commonly used drugs for more than 50 years has recently evolved into what can only be described as a phenomenon in the treatment of severe depression and suicidal ideation. Ketamine – a psychoactive analgesic (pain-blocking) sedative – is considered by many in the…

• 

  LegitScript Study Shows Widespread Problems and Potential Dangers in Online CBD Market

  

  By LegitScript Folks

  on October 21, 2019

  Over the past six months, LegitScript’s analysts and policy experts have been conducting a research project to better understand the online CBD landscape. We’ve looked at the state of compliance, the safety and accuracy of products, and issues around payment processing. What we found in this landmark report is nothing short of disturbing for both…

• 

  サプリメントや医薬品の個人輸入で健康被害を受けた方からの声を募集します

  

  By Hiromi

  on October 04, 2019

  レジットスクリプトは以前から、個人輸入として販売されている医薬品やサプリメントについての危険性を訴えています。厚労省も同様に注意喚起を行なっています。

• 

  E-money: A Case Study of Human Trafficking (Part 2)

  

  By LegitScript Folks

  on September 23, 2019

  In Part 1 of our series, we discussed electronic money and the rules that have allowed e-money institutions to flourish in the European Union with less regulations than banks. This week, we look at an example of how these European businesses have real and widespread influence on criminal operations in the US. A Haven for…

• 

  E-money: How Payment Complexity in Europe Facilitates Cybercrime in the US (Part 1)

  

  By LegitScript Folks

  on September 19, 2019

  Although electronic money has been around for decades, advancements in technology and new ways of processing payments are making it easier than ever to digitally store, send, and receive money. On the backend, however, e-money processing can be surprisingly complex, as transactions often pass through multiple entities to get from sender to receiver. It’s this…

• 

  Why Are Supplement Ingredient Names So Confusing?

  

  By LegitScript Folks

  on September 06, 2019

  Have you ever heard of 1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol or 4-[2-(dimethylamino)ethyl]phenol? Probably not. How about higenamine or hordenine? That may be more likely, but did you know that 1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol and higenamine are actually the same ingredient? The same is true for 4-[2-(dimethylamino)ethyl]phenol and hordenine. Ingredient names can be confusing because manufacturers don’t always follow guidelines set by the…

• 

  More Than Half of Online Drug Sellers Are Operating Illegally with Respect to Chinese Law and Regulation, New LegitScript and ASOP Global Study Finds

  

  By LegitScript Folks

  on August 15, 2019

  A new report on the Chinese internet pharmacy market by ASOP Global and LegitScript finds that most online drug sellers are operating illegally, and that a noteworthy percentage are illegally offering prescription drugs or controlled substances. The report, titled “The Chinese Internet Pharmacy Market Threat Assessment,” includes new information about the situation in China related…

• 

  Addiction Treatment Certification One Year In: Why It’s More Important Than Ever

  

  By David Khalaf

  on August 13, 2019

  LegitScript recently celebrated the one-year anniversary of the launch of our Drug and Alcohol Addiction Treatment Certification program, and our certification team reflected on both the  lessons and accomplishments of this monumental program. As a member of the customer success team, I see firsthand the value our customers get out of certification. But more importantly,…

• 

  Seizures Related to Vaping Highlight Risk of E-cigarette Merchants

  

  By LegitScript Folks

  on August 08, 2019

  The FDA said this week that it is investigating 127 incidents of people suffering from seizures after vaping. The news highlights the elevated risk e-cigarette products pose for legal violations, and why payment service providers should know about the many types of products and parts related to vaping to better monitor their portfolios. The FDA’s…

• 

  The Top Marketing Claims CBD Merchants and Manufacturers Should Avoid

  

  By David Khalaf

  on July 11, 2019

  One of the aspects of cannabidiol (CBD) sales that can attract regulatory scrutiny is the way in which merchants market their CBD products. In the past five years, the FDA has sent many warning letters to manufacturers and merchants of CBD products for claims that their products can prevent, cure, mitigate, or treat diseases. No…